Aberdeen Group’s 89bio ETNB Stock Holding History

Aberdeen Group’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-329,338	Closed	-$2.58M	–	949
2024 Q4	$2.58M	Sell	329,338 -141,049	-30%	-$1.16M	﹤0.01%	735
2024 Q3	$3.48M	Hold	470,387	–	–	0.01%	709
2024 Q2	$3.77M	Hold	470,387	–	–	0.01%	678
2024 Q1	$5.48M	Buy	470,387 +256,195	+120%	+$2.84M	0.01%	657
2023 Q4	$2.39M	Buy	+214,192	New	+$1.97M	0.01%	760

Other funds holding ETNB

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aberdeen Group's ETNB Position: Q1 2025 in Review

Aberdeen Group sold out of 89bio (ETNB) in Q1 2025, closing a stake of 329,338 shares — an estimated $2.58M sold.

Aberdeen Group first reported a position in ETNB in Q4 2023 and held it in 5 quarters. The position peaked at $5.48M in Q1 2024. 186 funds tracked by Wall St. Rank hold ETNB as of Q1 2025.

Aberdeen Group reported no remaining 89bio position as of Q1 2025 after selling out during the quarter.
Aberdeen Group sold 329,338 89bio shares in Q1 2025, an estimated $2.58M.
Aberdeen Group first reported a position in 89bio in Q4 2023 and held it in 5 quarters.
Aberdeen Group's 89bio position peaked at $5.48M in Q1 2024.
186 funds tracked by Wall St. Rank held 89bio as of Q1 2025.

Based on Aberdeen Group's 13F filing for Q1 2025, filed 13 May 2025.